(Q34563033)
Statements
1 reference
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (English)
1 reference
Everett E Vokes
1 reference
Ezra E W Cohen
1 reference
Madeleine A Kane
1 reference
Marcy A List
1 reference
Bruce E Brockstein
1 reference
Bhoomi Mehrotra
1 reference
Dezheng Huo
1 reference
Ann M Mauer
1 reference
Carolyn Pierce
1 reference
Allison Dekker
1 reference
1 December 2005
1 reference
1 reference
Identifiers
1 reference